TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27756265

Group type: EXPERIMENTAL
Intervention: Motivational counselling sessions and individual text message reminders for 16 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (usual lifestyle)
Number of subjects: 20
Study: 24720481

Group type: EXPERIMENTAL
Intervention: Persuasive message against legalisation of doping
Number of subjects: 0

Group type: COMPARATOR
Intervention: Persuasive message in favour of legalisation of doping
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High elaboration condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low elaboration condition
Number of subjects: 0
Study: 23669489

Group type: EXPERIMENTAL
Intervention: Active compression decompression cardiopulmonary resuscitation plus an impedance threshold device (ACD+ITD)
Number of subjects: 2738

Group type: COMPARATOR
Intervention: Standard cardiopulmonary resuscitation (S-CPR)
Number of subjects: 2738
Study: 19727956

Group type: EXPERIMENTAL
Intervention: Lamivudine with or without adefovir dipivoxil
Number of subjects: 79

Group type: COMPARATOR
Intervention: No antiviral treatment
Number of subjects: 79
Study: 18699977

Group type: EXPERIMENTAL
Intervention: Mosapride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Proton Pump Inhibitor (PPI) therapy
Number of subjects: 0
Study: 16886198

Group type: EXPERIMENTAL
Intervention: Thermal aerosol delivery of alprazolam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thermal aerosol delivery of prochlorperazine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rapid intravenous infusion
Number of subjects: 0
Study: 14644862

Group type: EXPERIMENTAL
Intervention: Glucocorticoid treatment (prednisone)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 9
Study: 10903217

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg once a day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8877261

Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg b.i.d.)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 1891610

Group type: EXPERIMENTAL
Intervention: Patient-controlled antiemetic therapy (PCAE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nurse-administered antiemetic therapy (NCAE)
Number of subjects: 20
Study: 6150491

Group type: EXPERIMENTAL
Intervention: 6 mg bromazepam daily for 3 weeks
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo daily for 3 weeks
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: 6 mg bromazepam
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 30526375

Group type: EXPERIMENTAL
Intervention: Court Surface (CS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Grass Surface (GS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tile Surface (TS)
Number of subjects: 40
Study: 30747551

Group type: EXPERIMENTAL
Intervention: Hydrothermally modified corn starch (HMS) ingestion (8% carbohydrate containing a total of 0.7 g·kg BM‐1·hr‐1; 2.8 kcal·kg BM‐1·hr‐1)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Isoenergetic dextrose
Number of subjects: 11
Study: 29502050

Group type: EXPERIMENTAL
Intervention: Pneumatic ballistic extracorporeal shock wave
Number of subjects: 77

Group type: COMPARATOR
Intervention: Ultrasound-guided hormone injection
Number of subjects: 77
Study: 27138575

Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg orally per day) plus Bevacizumab (15 mg/kg intravenously once every 3 weeks)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Letrozole (2.5 mg orally per day)
Number of subjects: 350
Study: 24620850

Group type: EXPERIMENTAL
Intervention: Hatha yoga program (HYP)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Attention control (AC) music or art class
Number of subjects: 31
Study: 21750975

Group type: EXPERIMENTAL
Intervention: Vibration Therapy (VT) - 5 sets of 1 min at 26 Hz, 6 mm peak-to-peak displacement
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control treatment (no VT)
Number of subjects: 8
Study: 20555372

Group type: EXPERIMENTAL
Intervention: ARGININE (3.0 g of arginine, 300 mg of grape seed extract, and 300 mg of polyethylene glycol)
Number of subjects: 41

Group type: COMPARATOR
Intervention: PLACEBO (microcrystalline cellulose)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: ARGININE
Number of subjects: 41

Group type: COMPARATOR
Intervention: PLACEBO
Number of subjects: 41
Study: 18278836

Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) therapy
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo (PLA) followed by Etanercept (ETN) therapy
Number of subjects: 257
Study: 16029070

Group type: EXPERIMENTAL
Intervention: NXY-059 (disufenton sodium) continuous intravenous infusion for 72 hours, including a 1-hour loading infusion
Number of subjects: 179
Study: 11763207

Group type: EXPERIMENTAL
Intervention: Life review intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 9597413

Group type: EXPERIMENTAL
Intervention: Spectral turbulence analysis (Group 1)
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Acceleration spectrum analysis (Group 1)
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Spectral temporal mapping (Group 1)
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Time-domain analysis (Group 1)
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Spectral turbulence analysis (Group 2)
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Acceleration spectrum analysis (Group 2)
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Spectral temporal mapping (Group 2)
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Time-domain analysis (Group 2)
Number of subjects: 634

Group type: COMPARATOR
Intervention: Control group (Group 3)
Number of subjects: 634
Study: 7822059

Group type: EXPERIMENTAL
Intervention: Low fluoride toothpaste (550 ppm)
Number of subjects: 1523

Group type: COMPARATOR
Intervention: Standard fluoride toothpaste (1050 ppm)
Number of subjects: 1523
Study: 3171790

Group type: EXPERIMENTAL
Intervention: Dhaka solution with dextrose (DS + D)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Dhaka solution without dextrose (DS)
Number of subjects: 67
Study: 30868637

Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard sural NCS
Number of subjects: 14
Study: 28419200

Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Ritonavir-boosted Lopinavir (LPV/r)
Number of subjects: 298
Study: 26106114

Group type: EXPERIMENTAL
Intervention: Intensive therapy (16 hours per week for 3 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Distributed therapy (6 hours per week for 8 weeks)
Number of subjects: 34
Study: 23675629

Group type: EXPERIMENTAL
Intervention: Exposure to electromagnetic radiation from a 2.4-GHz cordless phone base station (3‐8 µW/cm²) for 3‐min intervals
Number of subjects: 69
Study: 22069964

Group type: EXPERIMENTAL
Intervention: Endoscopic decompression via unilateral approach (group B)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Posterior lamina fenestration decompression (group A)
Number of subjects: 79
Study: 19218185

Group type: EXPERIMENTAL
Intervention: Personalized, single-session intervention delivered by a lay health adviser
Number of subjects: 266

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 266
Study: 17875958

Group type: EXPERIMENTAL
Intervention: Hyperuricemia (serum uric acid level, >7.0 mg/dL)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: History of gout
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 283
Study: 14759231

Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanate 2000/125 mg twice daily
Number of subjects: 1295

Group type: COMPARATOR
Intervention: Comparators (levofloxacin 500 mg once daily, clarithromycin 500 mg twice daily, amoxicillin/clavulanate 875/125 mg, and 1000/125 mg)
Number of subjects: 1295

Group type: COMPARATOR
Intervention: Comparators
Number of subjects: 1295
Study: 11567761

Group type: EXPERIMENTAL
Intervention: rhIL-12 (1 or 4 microg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 9632129

Group type: EXPERIMENTAL
Intervention: Running shoe with optimized forefoot pressure damping
Number of subjects: 0

Group type: COMPARATOR
Intervention: Custom-made soft insole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxford shoe
Number of subjects: 0
Study: 7868986

Group type: EXPERIMENTAL
Intervention: Oral estradiol, 2 mg daily
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol, 0.1 mg twice weekly
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 3336615

Group type: EXPERIMENTAL
Intervention: Ankle suspension method
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Thigh suspension method
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both methods (ankle and thigh suspension)
Number of subjects: 20
Study: 28934746

Group type: EXPERIMENTAL
Intervention: Dorsal temperature probe placement
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Thoracic temperature probe placement
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Axillary temperature probe placement
Number of subjects: 122
Study: 27211991

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Substance Education and Twelve-Step Introduction (SET)
Number of subjects: 586
Study: 25926532

Group type: EXPERIMENTAL
Intervention: Systematic AZA initiated ≤2 weeks from surgery
Number of subjects: 63

Group type: COMPARATOR
Intervention: Endoscopy-driven AZA initiated only in case of endoscopic recurrence (Rutgeerts' score ≥i2) at weeks 26 or 52
Number of subjects: 63
Study: 22692502

Group type: EXPERIMENTAL
Intervention: 12-months aged lysozyme-containing cheese
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 24-months aged lysozyme-containing cheese
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Lysozyme-specific IgE level higher than 7 kU/L
Number of subjects: 21

Group type: COMPARATOR
Intervention: Grana Padano cheese (not specified if lysozyme-containing)
Number of subjects: 21
Study: 21658562

Group type: EXPERIMENTAL
Intervention: CRT-D therapy (high responders)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ICD-only patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CRT-D therapy (low responders)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous measure of CRT-D response
Number of subjects: 0
Study: 19454868

Group type: EXPERIMENTAL
Intervention: Multidisciplinary (behavioral‐medical) rehabilitation alone
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation with subsequent booster sessions
Number of subjects: 363

Group type: COMPARATOR
Intervention: Traditional orthopedic rehabilitation
Number of subjects: 363
Study: 16684435

Group type: EXPERIMENTAL
Intervention: Silver textile (Group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Prednicarbate ointment (Group 3)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Silver-free textile (Group 2)
Number of subjects: 30
Study: 15230485

Group type: EXPERIMENTAL
Intervention: Isoflavones (90 mg daily for 6 weeks)
Number of subjects: 40
Study: 11299246

Group type: EXPERIMENTAL
Intervention: Percutaneous fluid-filled catheter
Number of subjects: 19

Group type: COMPARATOR
Intervention: Balloon-tipped catheter
Number of subjects: 19
Study: 7673989

Group type: EXPERIMENTAL
Intervention: Metastatic renal cell carcinoma patients with brain metastases (asymptomatic)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Subsequent cases of asymptomatic brain lesions
Number of subjects: 90
Study: 2096518

Group type: EXPERIMENTAL
Intervention: Ivermectin 100 micrograms/kg or greater
Number of subjects: 40
Study: 352376

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Debrisoquine
Number of subjects: 0
Study: 31979305

Group type: EXPERIMENTAL
Intervention: 800 mg of EGCG and 60 mL of coconut oil
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 51
Study: 30109588

Group type: EXPERIMENTAL
Intervention: Huannao Yicong Formula (HYF) 5 g granules twice daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Donepezil 5 mg once daily
Number of subjects: 60
Study: 28345499

Group type: EXPERIMENTAL
Intervention: Synbiotic supplement
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 25624756

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training, 3 sessions per week for 12 weeks
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (CG) without intervention
Number of subjects: 11
Study: 24372674

Group type: EXPERIMENTAL
Intervention: 0.2 mg tamsulosin once a day
Number of subjects: 108

Group type: COMPARATOR
Intervention: Conservative management only
Number of subjects: 108
Study: 22510279

Group type: EXPERIMENTAL
Intervention: Paula method (circular muscle exercises)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Pelvic floor muscle training (PFMT) exercises
Number of subjects: 126
Study: 20053273

Group type: EXPERIMENTAL
Intervention: WE CALL (multimodal support intervention comprising information, education and telephone support)
Number of subjects: 384

Group type: COMPARATOR
Intervention: YOU CALL (passive intervention providing the name and phone number of a resource person)
Number of subjects: 384
Study: 18350737

Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Orlistat
Number of subjects: 34
Study: 15361892

Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 85

Group type: COMPARATOR
Intervention: Nonstatin antihyperlipidaemic drug
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: All four antihyperlipidaemic drugs
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Statin groups (Fluvastatin, Simvastatin, Pravastatin)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Nonstatin group
Number of subjects: 85
Study: 11882512

Group type: EXPERIMENTAL
Intervention: Intravenous dideuterated Delta(5)-phytosterols and oral pentadeuterated Delta(5)-phytosterols
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 600 mg of soy stanols
Number of subjects: 10
Study: 10572324

Group type: EXPERIMENTAL
Intervention: Sertraline (50-150 mg)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Fluoxetine (20-60 mg)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 238

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 238
Study: 8926268

Group type: EXPERIMENTAL
Intervention: 4.2 MJ/day diet plus aerobic and anaerobic exercise
Number of subjects: 69

Group type: COMPARATOR
Intervention: 4.2 MJ/day diet
Number of subjects: 69
Study: 2071428

Group type: EXPERIMENTAL
Intervention: Sitting shower
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sitting sink bath
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bathing activity (both methods)
Number of subjects: 30
Study: 6403172

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hyperventilation of cold air
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hyperventilation of room air
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Inhalation of ultrasonically nebulised distilled water
Number of subjects: 14
Study: 31031050

Group type: EXPERIMENTAL
Intervention: Improved study features with 90% attendance in volunteer-based centers and 70% in population-based centers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2-year screen interval
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 80% biopsy compliance
Number of subjects: 0

Group type: COMPARATOR
Intervention: 30% attendance
Number of subjects: 0

Group type: COMPARATOR
Intervention: 40% biopsy compliance
Number of subjects: 0

Group type: COMPARATOR
Intervention: 100% contamination
Number of subjects: 0
Study: 29365017

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (successful reperfusion)
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (successful recanalization)
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Delayed reperfusion or lower Alberta Stroke Program Early Computed Tomography Score
Number of subjects: 462

Group type: COMPARATOR
Intervention: No reperfusion or recanalization
Number of subjects: 462
Study: 26778346

Group type: EXPERIMENTAL
Intervention: Improvement in visual acuity (VA)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Short time per specialist visit
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Change of VA
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Waiting, treatment, and travel time
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Treatment scheme
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Willingness to accept time per physician visit
Number of subjects: 284
Study: 25088843

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with alteplase at 0.6 mg/kg body weight
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 21369794

Group type: EXPERIMENTAL
Intervention: β‐TCP/Clg non‐membrane
Number of subjects: 20

Group type: COMPARATOR
Intervention: β‐TCP/Clg + barrier membrane
Number of subjects: 20
Study: 19082836

Group type: EXPERIMENTAL
Intervention: Carboxy-methylated cellulose (CMC) nasal packing
Number of subjects: 41

Group type: COMPARATOR
Intervention: No nasal packing (control)
Number of subjects: 41
Study: 17304142

Group type: EXPERIMENTAL
Intervention: LiftTrainer program (behavior-based lift training)
Number of subjects: 2144

Group type: COMPARATOR
Intervention: Video control group
Number of subjects: 2144

Group type: EXPERIMENTAL
Intervention: LiftTrainer program (for those with low twisting moments <30 Nm)
Number of subjects: 2144

Group type: COMPARATOR
Intervention: Video control group (for those with low twisting moments <30 Nm)
Number of subjects: 2144
Study: 15341352

Group type: EXPERIMENTAL
Intervention: CAF plus EMD
Number of subjects: 17

Group type: COMPARATOR
Intervention: CAF only
Number of subjects: 17
Study: 11180034

Group type: EXPERIMENTAL
Intervention: Seville orange juice
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dilute grapefruit juice
Number of subjects: 10

Group type: COMPARATOR
Intervention: Common orange juice (control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 6',7'-dihydroxybergamottin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bergapten
Number of subjects: 10
Study: 9675717

Group type: EXPERIMENTAL
Intervention: Exposed subjects to 2-alkoxyethanols and their acetates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 9414362

Group type: EXPERIMENTAL
Intervention: Box size variations (300, 450, 600 mm) and lifting frequency (1, 4, 6 lifts/min)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Box size variations and lifting frequency
Number of subjects: 13

Group type: COMPARATOR
Intervention: Chinese inexperienced male subjects
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Lifting frequency
Number of subjects: 13

Group type: COMPARATOR
Intervention: Chinese and Occidental subjects
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Body part RPE ratings
Number of subjects: 13
Study: 2718223

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 334500

Group type: EXPERIMENTAL
Intervention: Low-dose heparin (5000 IU daily, twice)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Combined heparin and dihydroergotamine (5000 IU heparin and 0.5 mg dihydroergotamine daily)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Control group (no prophylactic treatment)
Number of subjects: 362
Study: 28383172

Group type: EXPERIMENTAL
Intervention: Ti‐250 μm (group D)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ti‐no air abrasion (group A)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ti‐110 μm (group C)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ti‐air‐abraded with 50 μm (group B)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Co‐Cr‐50 μm (group E)
Number of subjects: 100
Study: 28657801

Group type: EXPERIMENTAL
Intervention: 20mg melatonin gargle before each irradiation and 20mg melatonin capsules nightly during 7 weeks of concurrent chemoradiation
Number of subjects: 39

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 39
Study: 26281607

Group type: EXPERIMENTAL
Intervention: High dose group (112 patients) for acute diarrhea
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Low dose group (113 patients) for acute diarrhea
Number of subjects: 507

Group type: COMPARATOR
Intervention: Positive control group (115 patients) for acute diarrhea
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: High dose group (56 patients) for chronic persistent diarrhea
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Low dose group (55 patients) for chronic persistent diarrhea
Number of subjects: 507

Group type: COMPARATOR
Intervention: Control group (56 patients) for chronic persistent diarrhea
Number of subjects: 507
Study: 22930219

Group type: EXPERIMENTAL
Intervention: 16-week home-based walking program
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups (independent of study group)
Number of subjects: 32
Study: 22254076

Group type: EXPERIMENTAL
Intervention: Folic acid 400 µg/day
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Folic acid 140 µg/day
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 19929183

Group type: EXPERIMENTAL
Intervention: Physical Activity on Prescription (PAP) programme with exercise twice a week, education, and motivational counselling
Number of subjects: 525

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Physical Activity on Prescription (PAP) programme
Number of subjects: 525
Study: 17046724

Group type: EXPERIMENTAL
Intervention: Delusional Assessment Scale (DAS)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Brief Psychiatric Rating Scale (BPRS)
Number of subjects: 92